Tau and Alzheimer's disease: the long road to anti-tangle therapeutics

J Mol Neurosci. 2002 Dec;19(3):249-50. doi: 10.1007/s12031-002-0001-y.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / metabolism*
  • Amyloid beta-Peptides / metabolism
  • Animals
  • Congresses as Topic
  • Disease Models, Animal
  • Enzyme Activators / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Mice
  • Mice, Transgenic
  • Neurofibrillary Tangles / drug effects
  • Neurofibrillary Tangles / metabolism*
  • Phosphoprotein Phosphatases / drug effects
  • Phosphoprotein Phosphatases / metabolism
  • Phosphorylation / drug effects
  • Phosphotransferases / antagonists & inhibitors
  • Phosphotransferases / metabolism
  • Protein Binding / drug effects
  • tau Proteins / metabolism*

Substances

  • Amyloid beta-Peptides
  • Enzyme Activators
  • Enzyme Inhibitors
  • tau Proteins
  • Phosphotransferases
  • Phosphoprotein Phosphatases